Virax Biolabs Group Cash Flow Statement 2020-2024 | VRAX

Fifteen years of historical annual cash flow statements for Virax Biolabs Group (VRAX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023202220212020
$-6.74$-5.46$-1.75$-0.67$0.00
$0.10$0$0$0$0
$1.51$1.46$0.29$0.02$0
$1.61$1.46$0.29$0.02$0
$0$0$0.00$0.00$0
$-0.06$0.02$0.00$-0.02$0
$0$0$0$0$0
$-0.49$-0.24$0.00$0$0
$-1.12$-0.18$0.64$0.06$0
$-6.25$-4.18$-0.81$-0.59$0
$-0.95$0$0$0$0
$-0.21$-0.18$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$-1.16$-0.18$0$0$0
$-0.15$0.15$0.10$0$0
$-0.06$0$0$0$0
$-0.21$0.15$0.10$0$0
$1.87$13.65$0.52$0.40$0
$1.87$13.65$0.52$0.40$0
$0$0$0$0$0
$-0.02$-0.11$0.19$0.18$0
$1.65$13.69$0.81$0.59$0
$-5.76$9.33$0.00$-0.01$0
$1.01$1.75$0.29$0$0
$0$0$0$0$0